The Effects of Clazakizumab on Peripheral Blood and Kidney Transcriptomes in Patients With Late Antibody-Mediated Rejection.

Kidney Int Rep · 2025 · PMC12640031 · PMID 41278310

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The brown module was downregulated in the CLZ-CLZ phase A and PBO-CLZ phase B samples (although this did not reach statistical significance) ( Figure 3 a).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.